Warren Dunnavant

Mr. Dunnavant is a Managing Director at H.C. Wainwright & Co., where he leads healthcare investment banking efforts in the life sciences sector. He brings over 15 years of corporate-finance and strategic transaction experience—having previously held senior roles with BMO Capital Markets, Oppenheimer & Co. and Roth Capital Partners—and has completed more than 100 capital markets and advisory transactions for biotechnology clients.

Warren’s expertise in structuring growth-stage financings, managing IPOs, RD funds, and strategic M&A makes him a cornerstone advisor for biotech companies pursuing innovation-driven expansion.